2 Results

People

  1. Drilon
    Drilon
  2. Schram
    Schram
  3. Arbour
    Arbour
  4. Bergagnini
    Bergagnini
  5. Chang
    Chang
  6. Chen
    Chen
  7. Jonsson
    Jonsson
  8. Lai
    Lai
  9. Mrad
    Mrad
  10. Sabari
    Sabari

Groups

  1. Department of Medicine (2)
  2. Early Drug Development Service (2)
  3. Gynecologic Medicine Service (2)
  4. Solid Tumor Oncology Division (2)
  5. Thoracic Oncology (2)
  6. Sloan Kettering Institute Postdocs (1)
  1. "brigatinib"
  2. "Solid Tumor Oncology Division"
  3. "2017"
  4. "Gynecologic Medicine Service"
Formats
  1. Journal Article (2)
Groups
  1. Department of Medicine (2)
  2. Early Drug Development Service (2)
  3. Gynecologic Medicine Service (2)
  4. Solid Tumor Oncology Division (2)
  5. Thoracic Oncology (2)
  6. Sloan Kettering Institute Postdocs (1)
People
  1. Alexander Drilon (2)
  2. Alison Schram (2)
  3. Chebli Mrad (1)
  4. Fernando Santini (1)
  5. Isabella Bergagnini (1)
  6. Joshua Sabari (1)

More People

Years
  1. 2017 (2)
Publications
  1. Nature Reviews Clinical Oncology (1)
  2. OncoTargets and Therapy (1)
Publishers
  1. Dove Medical Press Ltd (1)
  2. Nature Publishing Group (1)

Results (2)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fusions in solid tumours: Diagnostic strategies, targeted therapy, and acquired resistance
    Journal Article

    Schram, A. M.; Chang, M. T.; Jonsson, P.; Drilon, A.
    Nature Reviews Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
    Journal Article

    Sabari, J. K.; Santini, F. C.; Schram, A. M.; Bergagnini, I.; Chen, R.; Mrad, C.; Lai, W. V.; Arbour, K. C.; Drilon, A.
    OncoTargets and Therapy (2017)

    Fulltext@MSK | Save